• Event Type: Earnings Conference Call for discussion of quarterly results
  • Event Date & Time: Thursday, November 12, 2026 at 04:00 PM IST
  • Financial Period Discussed: Quarter and Half year ended September 30, 2026 (Q2 FY27)
  • Timing Context: The call was held post-announcement of Unaudited Standalone & Consolidated Financial Results
  • Management Participants: The disclosure was signed by Ram Agarwal, CEO & Whole Time Director (DIN: 01739245)
  • Recording Availability: The audio recording of the earnings conference call is available on the company's website at www.prostarm.com
  • Specific Link: https://prostarm.com/wp-content/uploads/2019/09/10049173.mp3
  • Regulatory Compliance: Disclosure made pursuant to Regulation 30 and 46(2) of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015

Additional Notes Section

  • Previous Communication: This disclosure references a previous letter dated November 04, 2026 that intimated about the earnings conference call
  • Financial Data Disclosure: No financial figures or performance metrics were disclosed in this announcement
  • Document Type: Regulatory filing signed digitally by CEO Ram Agarwal on November 12, 2026 at 18:09:55 +05:30